Post Traumatic Stress Disorder Clinical Trial
Official title:
The Landslide Disaster in Gjerdrum Municipality: Early Intervention and Health Trajectories After Mass Trauma
NCT number | NCT05042323 |
Other study ID # | Gjerdrum |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 15, 2021 |
Est. completion date | March 15, 2023 |
Verified date | September 2021 |
Source | Norwegian Center for Violence and Traumatic Stress Studies |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study has two aims. The first is to understand more of what may be typical health trajectories after mass trauma for children and adults and what predicts these trajectories. The second is to understand what may be effective early interventions to prevent long-term health and psychosocial problems for youth (6-19). Participants are recruited from an outreach program implemented after a landslide killed 11 persons and destroyed 33 houses in Gjerdrum in Norway. One third of the inhabitants were evacuated. All evacuated are contacted and screened for trauma related difficulties. Those who have significant post-trauma reactions are offered trauma focused interventions.
Status | Completed |
Enrollment | 10 |
Est. completion date | March 15, 2023 |
Est. primary completion date | August 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 19 Years |
Eligibility | Inclusion Criteria: - Exposed to the landslide - Between 6-19 years old - A score of 15 or more on the CATS - A score between 11 - 14 on the CATS and have additional problems that have started or worsened after the landslide. Exclusion Criteria: - Suicidal - Psychotic |
Country | Name | City | State |
---|---|---|---|
Norway | Norwegian center for violence and traumatic stress studies | Oslo |
Lead Sponsor | Collaborator |
---|---|
Norwegian Center for Violence and Traumatic Stress Studies |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Anxiety | Measured with Screen for Child Anxiety Related Emotional Disorders (SCARED-5 Item) | Pre-treatment | |
Other | Anxiety | Measured with SCARED-5 Item | After 5 weeks | |
Other | Anxiety | Measured with SCARED-5 Item | After 9 weeks | |
Other | Anxiety | Measured with SCARED-5 Item | After 21 weeks | |
Other | Anxiety | Measured with SCARED-5 Item | After 33 weeks | |
Other | Anxiety | Measured with SCARED-5 Item | After 45 weeks | |
Other | Anxiety | Measured with SCARED-5 Item | After 57 weeks | |
Primary | PTSD | Measured with the Child and adolescent trauma screen (CATS). Range 0-60. Higher score means worse outcome. | Pre-treatment | |
Primary | PTSD | Measured with the CATS (after 4-5 sessions) | After 5 weeks | |
Primary | PTSD | Measured with the CATS (for those who continue to Step two) | After 9 weeks | |
Primary | PTSD | Measured with the CATS | After 21 weeks | |
Primary | PTSD | Measured with the CATS | After 33 weeks | |
Primary | PTSD | Measured with the CATS | After 45 weeks | |
Primary | PTSD | Measured with the CATS | After 57 weeks | |
Secondary | Depression | Measured with Moods and feelings questionaire (MFQ-short). Range 0-13. Higher scores means worse outcome. | Pre-treatment | |
Secondary | Depression | Measured with MFQ-short | After 5 weeks | |
Secondary | Depression | Measured with MFQ-short | After 9 weeks | |
Secondary | Depression | Measured with MFQ-short | After 21 weeks | |
Secondary | Depression | Measured with MFQ-short | After 33 weeks | |
Secondary | Depression | Measured with MFQ-short | After 45 weeks | |
Secondary | Depression | Measured with MFQ-short | After 57 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Recruiting |
NCT05934175 -
Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder
|
N/A | |
Recruiting |
NCT05934162 -
Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD
|
N/A | |
Completed |
NCT04460014 -
Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT
|
N/A | |
Completed |
NCT05877807 -
Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
|
||
Active, not recruiting |
NCT05992649 -
The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject
|
N/A | |
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Not yet recruiting |
NCT05331534 -
Effect of Attentional Therapy on Post-traumatic Stress Disorder
|
N/A | |
Not yet recruiting |
NCT04076215 -
Biochemical and Physiological Response to Stressogenic Stimuli
|
N/A | |
Not yet recruiting |
NCT03649607 -
Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black
|
N/A | |
Not yet recruiting |
NCT02545192 -
A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments
|
Phase 1 | |
Completed |
NCT02329418 -
Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit
|
N/A | |
Active, not recruiting |
NCT00978484 -
A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder
|
Phase 3 | |
Completed |
NCT00760734 -
Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)
|
Phase 1 | |
Completed |
NCT03278171 -
Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
|
||
Recruiting |
NCT05874362 -
People Bereaved by Violent Death : Negative Event Biases and Temporal Perception
|
N/A | |
Terminated |
NCT03898843 -
Assisted Animal Therapy: ReAnimal
|
N/A | |
Recruiting |
NCT04747379 -
Psychological Effect of Explicit Recall After Sedation (PEERS)
|
||
Completed |
NCT03248167 -
Cannabidiol as a Treatment for AUD Comorbid With PTSD
|
Phase 1/Phase 2 |